# Cluster1-3 Analysis

## Proteins: 

ALDH1A3, ALOX12B, ANXA8L1, AP3S2, APOA1, AZGP1, BLMH, CCDC107, CD207, CES2, CLIC3, CPM, CRABP2, CRYBG1, CTSH, CTSV, DEF8, DMKN, DOCK6, DSC2, ECM1, EPHX2, ESRP1, EVPL, FCGBP, GLUL, GTF2A2, HAL, HES1, HEY1, HSPB8, IL36G, IMPA2, JPH3, LGALSL, ME1, NAPRT, NLRP10, OLFM4, PLA2G4D, PPL, PRKACG, PYCARD, RAB25, RAPSN, RSRP1, S100A16, SCEL, SERPINB7, SPTBN2, SULT2B1, TALDO1, TFAP2D, TRIM29, TSN, TYMP, VHL, YOD1, ZG16B

### Extracellular Matrix and Immune Response System

**Summary**

The human protein system analyzed here consists of 52 proteins, with a majority involved in protein binding (42 proteins) and located in the cytosol (31 proteins). The system appears to be involved in extracellular matrix organization and immune response processes. Key proteins in this system include OLFM4, PPL, CLIC3, AZGP1, RSRP1, and ECM1, among others. The proteins are involved in various cellular components and complexes, such as extracellular exosomes, cytoplasm, nucleus, and plasma membrane. The biological processes performed by this system include signal transduction, cell adhesion, angiogenesis, innate immune response, and apoptotic processes. Based on the cellular location and function, the proposed name for this system is the "Extracellular Matrix and Immune Response System."

**References**

1. OLFM4: Liu, W., Rodgers, G. P. (2009). Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. *Cancer and Metastasis Reviews*, 28(1-2), 35-41. [DOI: 10.1007/s10555-008-9160-5](https://doi.org/10.1007/s10555-008-9160-5)

2. PPL: Kazerounian, S., Uitto, J., Aho, S. (2002). Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin. *Experimental Dermatology*, 11(5), 428-438. [DOI: 10.1034/j.1600-0625.2002.110504.x](https://doi.org/10.1034/j.1600-0625.2002.110504.x)

3. CLIC3: Berryman, M., Bretscher, A. (2000). Identification of a novel member of the chloride intracellular channel gene family (CLIC5) that associates with the actin cytoskeleton of placental microvilli. *Molecular Biology of the Cell*, 11(5), 1509-1521. [DOI: 10.1091/mbc.11.5.1509](https://doi.org/10.1091/mbc.11.5.1509)

4. AZGP1: Hassan, M. I., Waheed, A., Yadav, S., Singh, T. P., Ahmad, F. (2008). Zinc Î±2-glycoprotein: a multidisciplinary protein. *Molecular Cancer Research*, 6(6), 892-906. [DOI: 10.1158/1541-7786.MCR-07-2157](https://doi.org/10.1158/1541-7786.MCR-07-2157)

5. RSRP1: Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., Carstens, R. P. (2009). ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. *Molecular Cell*, 33(5), 591-601. [DOI: 10.1016/j.molcel.2009.01.025](https://doi.org/10.1016/j.molcel.2009.01.025)

6. ECM1: Sercu, S., Zhang, M., Oyama, N., Hansen, U., Ghalbzouri, A. E., Jun, G., Geerts, D., Komuta, M., Lorenzon, G., Lavrijsen, A. P., Uitto, J., Kas, K., Van Den Steen, P. E., Opdenakker, G., Steen, K., Merregaert, J. (2008). Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. *Journal of Investigative Dermatology*, 128(6), 1397-1408. [DOI: 10.1038/sj.jid.5701219](https://doi.org/10.1038/sj.jid.5701219)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 42 | OLFM4, PPL, CLIC3, AZGP1, RSRP1, ECM1, IMPA2, ESRP1, TRIM29, LGALSL, TYMP, PYCARD, CTSH, BLMH, NAPRT, DSC2, DOCK6, PRKACG, DMKN, S100A16, CTSV, APOA1, GLUL, TALDO1, SULT2B1, SCEL, TFAP2D, CRABP2, HSPB8, VHL, FCGBP, CD207, ZG16B, RAB25, TSN, ME1, HES1, CCDC107, GTF2A2, HEY1, JPH3, YOD1 |
| cytosol | 31 | OLFM4, PPL, EVPL, NLRP10, IMPA2, TYMP, PYCARD, CTSH, ALOX12B, BLMH, NAPRT, IL36G, DOCK6, PRKACG, HAL, S100A16, EPHX2, PLA2G4D, APOA1, GLUL, TALDO1, SULT2B1, CRABP2, HSPB8, VHL, RAPSN, SPTBN2, TSN, ME1, ALDH1A3, YOD1 |
| extracellular exosome | 23 | OLFM4, PPL, CLIC3, AZGP1, EVPL, ECM1, CTSH, BLMH, NAPRT, DSC2, S100A16, EPHX2, APOA1, GLUL, TALDO1, SULT2B1, SCEL, CRABP2, FCGBP, ZG16B, RAB25, CPM, ALDH1A3 |
| cytoplasm | 21 | PPL, CLIC3, EVPL, NLRP10, IMPA2, PYCARD, BLMH, GLUL, TALDO1, SULT2B1, SCEL, CRABP2, HSPB8, SERPINB7, TSN, ME1, HES1, ALDH1A3, ANXA8L1, HEY1, YOD1 |
| nucleus | 19 | CLIC3, AZGP1, RSRP1, ESRP1, PYCARD, BLMH, PRKACG, S100A16, GLUL, TALDO1, SULT2B1, TFAP2D, CRABP2, HSPB8, VHL, TSN, HES1, GTF2A2, HEY1 |
| extracellular space | 14 | OLFM4, AZGP1, ECM1, CTSH, IL36G, DMKN, S100A16, CTSV, APOA1, SERPINB7, FCGBP, ZG16B, CPM, SPTBN2 |
| nucleoplasm | 13 | OLFM4, NLRP10, ESRP1, PYCARD, IL36G, PRKACG, CRABP2, HSPB8, VHL, TSN, HES1, GTF2A2, HEY1 |
| plasma membrane | 13 | OLFM4, PPL, DSC2, IL36G, S100A16, APOA1, GLUL, RAPSN, CD207, RAB25, CPM, SPTBN2, JPH3 |
| extracellular region | 10 | OLFM4, AZGP1, ECM1, PYCARD, CTSH, NAPRT, IL36G, CTSV, APOA1, CPM |
| protein homodimerization activity | 10 | IMPA2, TYMP, PYCARD, S100A16, EPHX2, APOA1, HSPB8, HES1, ALDH1A3, GTF2A2 |
| identical protein binding | 8 | TRIM29, PYCARD, BLMH, APOA1, GLUL, HSPB8, TSN, ME1 |
| signal transduction | 7 | OLFM4, CLIC3, ECM1, IMPA2, TYMP, PYCARD, CRABP2 |
| membrane | 7 | PPL, CLIC3, EVPL, PLA2G4D, VHL, CCDC107, JPH3 |
| endoplasmic reticulum | 7 | PYCARD, DSC2, SULT2B1, CRABP2, VHL, CES2, TSN |
| metal ion binding | 6 | IMPA2, NAPRT, SCEL, RAPSN, DEF8, YOD1 |
|  gene expression | 6 | CTSH, ALOX12B, IL36G, EPHX2, VHL, HES1 |
| intracellular membrane-bounded organelle | 6 | CTSH, ALOX12B, SULT2B1, CES2, AP3S2, SPTBN2 |
| mitochondrion | 5 | OLFM4, PYCARD, GLUL, VHL, ME1 |
| perinuclear region of cytoplasm | 5 | OLFM4, ALOX12B, DOCK6, S100A16, SCEL |
|  transcription by RNA polymerase II | 5 | ECM1, TFAP2D, HES1, GTF2A2, HEY1 |
| cadherin binding | 4 | OLFM4, PPL, EVPL, SPTBN2 |
| cell adhesion | 4 | OLFM4, AZGP1, DSC2, HES1 |
| protein-containing complex | 4 | OLFM4, PYCARD, GLUL, HES1 |
| cornified envelope | 4 | PPL, EVPL, DSC2, SCEL |
| collagen-containing extracellular matrix | 4 | AZGP1, ECM1, CTSH, APOA1 |
| angiogenesis | 4 | ECM1, TYMP, GLUL, HEY1 |
| innate immune response | 4 | NLRP10, TRIM29, PYCARD, IL36G |
| carbohydrate binding | 4 | LGALSL, CRYBG1, CD207, ZG16B |
| apoptotic process | 4 | PYCARD, CTSH, CTSV, ALDH1A3 |
|  cell population proliferation | 4 | CTSH, TFAP2D, RAB25, HES1 |
| calcium ion binding | 4 | DSC2, S100A16, PLA2G4D, ANXA8L1 |
| structural molecule activity | 3 | OLFM4, PPL, EVPL |
|  apoptotic process | 3 | OLFM4, PYCARD, ALDH1A3 |
|  phagocytosis | 3 | OLFM4, PYCARD, APOA1 |
| desmosome | 3 | PPL, EVPL, DSC2 |
| immune response | 3 | AZGP1, CTSH, CTSV |
| negative regulation of cell population proliferation | 3 | AZGP1, SULT2B1, VHL |
| epidermis development | 3 | EVPL, SCEL, CRABP2 |
| inflammatory response | 3 | ECM1, NLRP10, PYCARD |
| ATP binding | 3 | NLRP10, PRKACG, GLUL |
| negative regulation of transcription by RNA polymerase II | 3 | TRIM29, HES1, HEY1 |
| lysosome | 3 | TRIM29, CTSH, CTSV |
| cysteine-type endopeptidase activator activity involved in apoptotic process | 3 | PYCARD, CTSH, CTSV |
| enzyme binding | 3 | PYCARD, APOA1, VHL |
| secretory granule lumen | 3 | PYCARD, CTSH, APOA1 |
| cysteine-type endopeptidase activity | 3 | CTSH, BLMH, CTSV |
| cysteine-type peptidase activity | 3 | CTSH, BLMH, CTSV |
| proteolysis | 3 | CTSH, BLMH, VHL |
| cytoplasmic vesicle | 3 | DSC2, APOA1, RAB25 |
| molecular_function | 3 | CRYBG1, ZG16B, JPH3 |
| magnesium ion binding | 3 | EPHX2, GLUL, ME1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 3 | TFAP2D, HES1, HEY1 |
| chromatin | 3 | TFAP2D, HES1, HEY1 |
| Golgi apparatus | 3 | RAPSN, AP3S2, RAB25 |
| RNA polymerase II-specific DNA-binding transcription factor binding | 3 | HES1, GTF2A2, HEY1 |
|  substrate adhesion-dependent cell spreading | 2 | OLFM4, APOA1 |
| tertiary granule lumen | 2 | OLFM4, CTSH |
| structural constituent of cytoskeleton | 2 | PPL, SPTBN2 |
| response to mechanical stimulus | 2 | PPL, SCEL |
| keratinization | 2 | PPL, EVPL |
| wound healing | 2 | PPL, EVPL |
| intermediate filament cytoskeleton organization | 2 | PPL, EVPL |
| intermediate filament | 2 | PPL, EVPL |
| nuclear body | 2 | CLIC3, ESRP1 |
| retina homeostasis | 2 | AZGP1, ZG16B |
| external side of plasma membrane | 2 | AZGP1, CD207 |
| keratinocyte differentiation | 2 | EVPL, SCEL |
| protease binding | 2 | ECM1, PYCARD |
|  angiogenesis | 2 | ECM1, CTSH |
|  T cell migration | 2 | ECM1, PYCARD |
| extracellular matrix | 2 | ECM1, FCGBP |
| GTPase activity | 2 | NLRP10, RAB25 |
| adaptive immune response | 2 | NLRP10, CTSH |
|  interleukin-6 production | 2 | NLRP10, PYCARD |
|  interleukin-8 production | 2 | NLRP10, PYCARD |
|  inflammatory response | 2 | NLRP10, PYCARD |
| defense response to Gram-negative bacterium | 2 | NLRP10, PYCARD |
| mRNA binding | 2 | ESRP1, TSN |
| zinc ion binding | 2 | TRIM29, CPM |
| cell-cell adhesion | 2 | TRIM29, DSC2 |
| adherens junction | 2 | TRIM29, DSC2 |
| protein dimerization activity | 2 | PYCARD, HEY1 |
|  GTPase activity | 2 | PYCARD, DOCK6 |
| defense response to virus | 2 | PYCARD, CD207 |
| cellular response to lipopolysaccharide | 2 | PYCARD, IL36G |
| cellular response to interleukin-1 | 2 | PYCARD, HES1 |
| cellular response to tumor necrosis factor | 2 | PYCARD, HES1 |
| nucleolus | 2 | PYCARD, S100A16 |
| azurophil granule lumen | 2 | PYCARD, NAPRT |
| neuronal cell body | 2 | PYCARD, SPTBN2 |
| aminopeptidase activity | 2 | CTSH, BLMH |
| serine-type endopeptidase activity | 2 | CTSH, CTSV |
| thyroid hormone binding | 2 | CTSH, ALDH1A3 |
|  epithelial cell migration | 2 | CTSH, RAB25 |
|  peptidase activity | 2 | CTSH, CTSV |
| negative regulation of apoptotic process | 2 | CTSH, VHL |
| proteolysis involved in protein catabolic process | 2 | CTSH, CTSV |
| ERK1 and ERK2 cascade | 2 | CTSH, APOA1 |
|  apoptotic signaling pathway | 2 | CTSH, CTSV |
| carboxypeptidase activity | 2 | BLMH, CPM |
| response to toxic substance | 2 | BLMH, EPHX2 |
| cellular response to starvation | 2 | DSC2, GLUL |
| high-density lipoprotein particle assembly | 2 | PRKACG, APOA1 |
| RNA binding | 2 | S100A16, TSN |
| cholesterol homeostasis | 2 | EPHX2, APOA1 |
|  cholesterol metabolic process | 2 | EPHX2, APOA1 |
| calcium-dependent phospholipid binding | 2 | PLA2G4D, ANXA8L1 |
| phospholipid binding | 2 | APOA1, SPTBN2 |
| cholesterol binding | 2 | APOA1, SULT2B1 |
| cholesterol metabolic process | 2 | APOA1, SULT2B1 |
| protein stabilization | 2 | APOA1, VHL |
| early endosome | 2 | APOA1, AP3S2 |
| endoplasmic reticulum lumen | 2 | APOA1, CES2 |
| endocytic vesicle | 2 | APOA1, CD207 |
| manganese ion binding | 2 | GLUL, ME1 |
|  epithelial cell proliferation | 2 | GLUL, HES1 |
| carbohydrate metabolic process | 2 | TALDO1, ME1 |
| transcription by RNA polymerase II | 2 | TFAP2D, GTF2A2 |
| retinoic acid biosynthetic process | 2 | CRABP2, ALDH1A3 |
|  DNA-templated transcription | 2 | CRABP2, VHL |
| negative regulation of gene expression | 2 | VHL, HES1 |
| vesicle-mediated transport | 2 | AP3S2, SPTBN2 |
| presynapse | 2 | AP3S2, SPTBN2 |
| cell junction | 2 | SPTBN2, GTF2A2 |
| DNA binding | 2 | TSN, HES1 |
| sequence-specific DNA binding | 2 | TSN, HES1 |
| protein homotetramerization | 2 | ME1, ALDH1A3 |
| DNA-binding transcription repressor activity, RNA polymerase II-specific | 2 | HES1, HEY1 |
| sequence-specific double-stranded DNA binding | 2 | HES1, HEY1 |
| Notch signaling pathway | 2 | HES1, HEY1 |
| anterior/posterior pattern specification | 2 | HES1, HEY1 |
| negative regulation of neuron differentiation | 2 | HES1, HEY1 |
| negative regulation of DNA-templated transcription | 2 | HES1, HEY1 |
|  neurogenesis | 2 | HES1, HEY1 |
| ventricular septum morphogenesis | 2 | HES1, HEY1 |
| labyrinthine layer blood vessel development | 2 | HES1, HEY1 |
| neuromuscular process controlling balance | 2 | ALDH1A3, JPH3 |

